How Life Sciences Can Treat AI Regulatory Compliance

Artificial intelligence, particularly machine learning, encompasses a multifaceted set of technologies with many applications in the life sciences sector, such as cure research, diagnosis, and treatment, mitigation and prevention. Despite the vast potential of AI, the AI regulatory field is in full bloom in some places and merely bare branches elsewhere – depending on public […]

Read More

AI in Life Sciences: Faster Cures for Viral Disease

COVID-19 is upending life as we know it. The potential effect of this viral disease on mortality and public health, as well as the lasting socioeconomic impact of the crisis, is unfathomable. To mitigate the wide-scale impact of this growing pandemic, our hopes are trained on a vaccine, prophylactic or curative, and the life sciences […]

Read More

Value-Based Care in Life Sciences: What’s It Worth to You?

Just one of the many changes rippling through the life sciences industry is the gradual but inexorable shift of value-based care (VBC) becoming a leading means of healthcare insurance reimbursement. According to our recently sponsored research, as many as 150 biopharmaceutical drugs  are covered by value-based contracts, with a projected growth rate of 15% to […]

Read More

Disaggregation of Healthcare: The Great Unbundling Proceeds

In discussions with our clients, it’s become apparent that one of the greatest changes we’re witnessing in healthcare is the disaggregation (or unbundling) of care. Historically, access to and delivery of healthcare took place primarily in doctors’ offices, hospitals and clinics.  However, changes in consumer sentiment and advances in technology are creating a far more […]

Read More

From ‘-Omics’ to Digital Twins, Life Sciences Is In for Vast Changes Ahead

Digital tools and platforms are remaking every aspect of the life sciences (LS) value chain, from co-prescribed apps to implanted sensors to data queries for drug discovery, and digital is overturning how companies conduct clinical trials and manage production/distribution. The changes extend to how individual patients assimilate and internalize health and healthcare technology directly, through […]

Read More

From ‘Ensuring Customer Experience’ to ‘Assuring Trust’: Rethinking the Role of QA

Imagine a short circuit triggers a fire in your building while you’re at work, and the smoke detector in your smart home fails to raise an alarm. Or you receive a notification that your bank account was compromised because the bank’s mobile application had experienced a cyber attack. Or the insulin-monitoring digital pill miscalculates your […]

Read More

The Frontier Within (Part 3): Green Signals from the FDA for Human Digitization

This is the third in our blog series on “digitizing the human body.” (Also see Part 1 and Part 2.) Human digitization has moved closer to reality, with three recent FDA-related developments strongly suggesting that regulatory hurdles to cutting-edge life sciences technologies are less daunting than generally assumed:  #1: Approval of a Digital Pill The […]

Read More

Drones in Human Health: Transforming Life Sciences in the Wilds of the Healthcare Jungle (Part 2)

In Part 1 of this series, I discussed Dian Fossey’s approach to gaining groundbreaking insights on primate behavior by directly observing and documenting the daily activities of gorillas in their natural environment. I described how applying and combining digital technologies such as drones and artificial intelligence (AI) could enable Fossey-style research at scale to improve […]

Read More

Drones in Animal Health: Transforming Life Sciences in the Wilds of the Healthcare Jungle (Part 1)

In the 20th century, the world gained industry-changing insights on primate behavior when researcher Dian Fossey went to the remote forests of Rwanda to study the daily activities of gorillas in their natural environment. How can we reimagine this model of observation and understanding of the animal world with the digital tools we now have […]

Read More
X Close